HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-FEB-11 3QKK TITLE SPIROCHROMANE AKT INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: PROTEIN KINASE B, PKB, PROTO-ONCOGENE C-AKT, RAC-PK-ALPHA; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: GSK-3 BETA PEPTIDE; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT1, PKB, RAC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS KINASE DOMAIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.C.KALLAN,K.L.SPENCER,J.F.BLAKE,R.XU,J.HEIZER,J.R.BENCSIK, AUTHOR 2 I.S.MITCHELL,S.L.GLOOR,M.MARTINSON,T.RISOM,S.D.GROSS,T.MORALES, AUTHOR 3 G.P.A.VIGERS,B.J.BRANDHUBER,N.J.SKELTON REVDAT 2 20-APR-11 3QKK 1 JRNL REVDAT 1 30-MAR-11 3QKK 0 JRNL AUTH N.C.KALLAN,K.L.SPENCER,J.F.BLAKE,R.XU,J.HEIZER,J.R.BENCSIK, JRNL AUTH 2 I.S.MITCHELL,S.L.GLOOR,M.MARTINSON,T.RISOM,S.D.GROSS, JRNL AUTH 3 T.H.MORALES,W.I.WU,G.P.VIGERS,B.J.BRANDHUBER,N.J.SKELTON JRNL TITL DISCOVERY AND SAR OF SPIROCHROMANE AKT INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 21 2410 2011 JRNL REFN ISSN 0960-894X JRNL PMID 21392984 JRNL DOI 10.1016/J.BMCL.2011.02.073 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 16580 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 843 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 732 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.2310 REMARK 3 BIN FREE R VALUE SET COUNT : 33 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2755 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 121 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.70000 REMARK 3 B22 (A**2) : -0.29000 REMARK 3 B33 (A**2) : -0.41000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.245 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.183 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.210 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2860 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3853 ; 1.353 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 334 ; 6.541 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 139 ;35.961 ;23.381 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 513 ;17.483 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;24.652 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 399 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2155 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1674 ; 0.670 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2695 ; 1.289 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1186 ; 1.896 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1158 ; 3.122 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3QKK COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-FEB-11. REMARK 100 THE RCSB ID CODE IS RCSB063761. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-NOV-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17466 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : 0.11000 REMARK 200 FOR THE DATA SET : 8.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.28000 REMARK 200 R SYM FOR SHELL (I) : 0.24000 REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.52 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8.1MG/ML PROTEIN, 0.6MM GSK-3 BETA REMARK 280 PEPTIDE, 5MM MG-AMPPNP, 10MM DTT, 20% PEG 4K, 10% ISOPROPANOL, REMARK 280 0.1M HEPES, PH 7.8, UNDER OIL, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.79500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.67450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.40700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.67450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.79500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.40700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 140 REMARK 465 ALA A 141 REMARK 465 MET A 142 REMARK 465 ALA A 143 REMARK 465 THR A 450 REMARK 465 PRO A 451 REMARK 465 PRO A 452 REMARK 465 ASP A 453 REMARK 465 GLN A 454 REMARK 465 ASP A 455 REMARK 465 ASP A 456 REMARK 465 SER A 457 REMARK 465 THR A 479 REMARK 465 ALA A 480 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 153 -63.79 -101.96 REMARK 500 ARG A 243 -49.55 76.38 REMARK 500 ARG A 273 -12.12 79.72 REMARK 500 ASP A 292 85.00 52.70 REMARK 500 ASP A 302 -104.62 42.64 REMARK 500 ASP A 325 146.16 77.50 REMARK 500 ASP A 398 -126.65 59.97 REMARK 500 GLN A 428 44.38 -100.39 REMARK 500 GLN A 445 -161.26 -74.97 REMARK 500 ILE A 447 -99.13 -103.97 REMARK 500 PHE A 472 65.43 -100.19 REMARK 500 ASP A 473 30.41 -151.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SMH A 1 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OCB RELATED DB: PDB REMARK 900 RELATED ID: 3QKL RELATED DB: PDB REMARK 900 RELATED ID: 3QKM RELATED DB: PDB DBREF 3QKK A 144 480 UNP P31749 AKT1_HUMAN 144 480 SEQADV 3QKK GLY A 140 UNP P31749 EXPRESSION TAG SEQADV 3QKK ALA A 141 UNP P31749 EXPRESSION TAG SEQADV 3QKK MET A 142 UNP P31749 EXPRESSION TAG SEQADV 3QKK ALA A 143 UNP P31749 EXPRESSION TAG SEQADV 3QKK ASP A 473 UNP P31749 SER 473 ENGINEERED MUTATION SEQADV 3QKK SER A 478 UNP P31749 GLY 478 CONFLICT SEQRES 1 A 341 GLY ALA MET ALA ARG VAL THR MET ASN GLU PHE GLU TYR SEQRES 2 A 341 LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL ILE SEQRES 3 A 341 LEU VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA MET SEQRES 4 A 341 LYS ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP GLU SEQRES 5 A 341 VAL ALA HIS THR LEU THR GLU ASN ARG VAL LEU GLN ASN SEQRES 6 A 341 SER ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER PHE SEQRES 7 A 341 GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR ALA SEQRES 8 A 341 ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU ARG SEQRES 9 A 341 VAL PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA GLU SEQRES 10 A 341 ILE VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS ASN SEQRES 11 A 341 VAL VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET LEU SEQRES 12 A 341 ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU SEQRES 13 A 341 CYS LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS TPO SEQRES 14 A 341 PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU SEQRES 15 A 341 GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY SEQRES 16 A 341 LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU SEQRES 17 A 341 PRO PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU LEU SEQRES 18 A 341 ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU GLY SEQRES 19 A 341 PRO GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS LYS SEQRES 20 A 341 ASP PRO LYS GLN ARG LEU GLY GLY GLY SER GLU ASP ALA SEQRES 21 A 341 LYS GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE VAL SEQRES 22 A 341 TRP GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO PHE SEQRES 23 A 341 LYS PRO GLN VAL THR SER GLU THR ASP THR ARG TYR PHE SEQRES 24 A 341 ASP GLU GLU PHE THR ALA GLN MET ILE THR ILE THR PRO SEQRES 25 A 341 PRO ASP GLN ASP ASP SER MET GLU CYS VAL ASP SER GLU SEQRES 26 A 341 ARG ARG PRO HIS PHE PRO GLN PHE ASP TYR SER ALA SER SEQRES 27 A 341 SER THR ALA SEQRES 1 C 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU MODRES 3QKK TPO A 308 THR PHOSPHOTHREONINE HET TPO A 308 11 HET SMH A 1 38 HETNAM TPO PHOSPHOTHREONINE HETNAM SMH N-(2-ETHOXYETHYL)-N-{(2S)-2-HYDROXY-3-[(2R)-6-HYDROXY- HETNAM 2 SMH 4-OXO-3,4-DIHYDRO-1'H-SPIRO[CHROMENE-2,3'-PIPERIDIN]- HETNAM 3 SMH 1'-YL]PROPYL}-2,6-DIMETHYLBENZENESULFONAMIDE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 3 SMH C28 H38 N2 O7 S FORMUL 4 HOH *121(H2 O) HELIX 1 1 THR A 146 ASN A 148 5 3 HELIX 2 2 LYS A 183 LYS A 189 1 7 HELIX 3 3 GLU A 191 SER A 205 1 15 HELIX 4 4 LEU A 235 ARG A 243 1 9 HELIX 5 5 SER A 246 ASN A 269 1 24 HELIX 6 6 THR A 312 LEU A 316 5 5 HELIX 7 7 ALA A 317 ASP A 323 1 7 HELIX 8 8 ALA A 329 GLY A 345 1 17 HELIX 9 9 ASP A 353 GLU A 364 1 12 HELIX 10 10 GLY A 373 LEU A 384 1 12 HELIX 11 11 ASP A 398 GLN A 404 1 7 HELIX 12 12 HIS A 405 ALA A 409 5 5 HELIX 13 13 VAL A 412 GLU A 418 1 7 HELIX 14 14 ASP A 439 ALA A 444 1 6 SHEET 1 A 6 PHE A 150 GLY A 159 0 SHEET 2 A 6 GLY A 162 GLU A 169 -1 O LEU A 166 N LYS A 154 SHEET 3 A 6 TYR A 175 LYS A 182 -1 O ILE A 180 N LYS A 163 SHEET 4 A 6 ARG A 222 GLU A 228 -1 O PHE A 225 N LYS A 179 SHEET 5 A 6 LEU A 213 GLN A 218 -1 N LYS A 214 O VAL A 226 SHEET 6 A 6 ASP A 473 SER A 475 -1 O TYR A 474 N SER A 216 SHEET 1 B 3 GLY A 233 GLU A 234 0 SHEET 2 B 3 LEU A 280 LEU A 282 -1 O LEU A 282 N GLY A 233 SHEET 3 B 3 ILE A 288 ILE A 290 -1 O LYS A 289 N MET A 281 SHEET 1 C 2 CYS A 310 GLY A 311 0 SHEET 2 C 2 PHE C 8 ALA C 9 -1 O PHE C 8 N GLY A 311 LINK C LYS A 307 N TPO A 308 1555 1555 1.34 LINK C TPO A 308 N PHE A 309 1555 1555 1.34 SITE 1 AC1 19 HOH A 84 LEU A 156 GLY A 157 LYS A 158 SITE 2 AC1 19 PHE A 161 GLY A 162 VAL A 164 ALA A 177 SITE 3 AC1 19 LYS A 179 GLU A 191 THR A 195 ALA A 230 SITE 4 AC1 19 GLU A 234 GLU A 278 ASN A 279 MET A 281 SITE 5 AC1 19 THR A 291 ASP A 292 PHE A 438 CRYST1 47.590 56.814 151.349 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021013 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017601 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006607 0.00000